Literature DB >> 14633822

Why can't we prevent type 1 diabetes?: maybe it's time to try a different combination.

Desmond Schatz1, Edwin A M Gale, Mark A Atkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14633822     DOI： 10.2337/diacare.26.12.3326

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  14 in total

1.  Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

Authors:  Paolo Fiorina; Mollie Jurewicz; Andrea Augello; Andrea Vergani; Shirine Dada; Stefano La Rosa; Martin Selig; Jonathan Godwin; Kenneth Law; Claudia Placidi; R Neal Smith; Carlo Capella; Scott Rodig; Chaker N Adra; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

2.  Is ARE/poly(U)-binding factor 1 (AUF1) a new player in cytokine-mediated beta cell apoptosis?

Authors:  E C Vanzela; A K Cardozo
Journal:  Diabetologia       Date:  2012-04-19       Impact factor: 10.122

3.  Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.

Authors:  Michael J Haller; Stephen E Gitelman; Peter A Gottlieb; Aaron W Michels; Stephen M Rosenthal; Jonathan J Shuster; Baiming Zou; Todd M Brusko; Maigan A Hulme; Clive H Wasserfall; Clayton E Mathews; Mark A Atkinson; Desmond A Schatz
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

Review 4.  Autologous umbilical cord blood infusion for type 1 diabetes.

Authors:  Michael J Haller; Hilla-Lee Viener; Clive Wasserfall; Todd Brusko; Mark A Atkinson; Desmond A Schatz
Journal:  Exp Hematol       Date:  2008-03-20       Impact factor: 3.084

5.  The road not taken: a path to curing type 1 diabetes?

Authors:  Michael J Haller; Mark A Atkinson; Desmond A Schatz
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

6.  Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.

Authors:  Michael J Haller; Desmond A Schatz; Jay S Skyler; Jeffrey P Krischer; Brian N Bundy; Jessica L Miller; Mark A Atkinson; Dorothy J Becker; David Baidal; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Kevan C Herold; Jennifer B Marks; Antoinette Moran; Henry Rodriguez; William Russell; Darrell M Wilson; Carla J Greenbaum
Journal:  Diabetes Care       Date:  2018-07-16       Impact factor: 19.112

7.  Induction of protective genes leads to islet survival and function.

Authors:  Hongjun Wang; Christiane Ferran; Chiara Attanasio; Fulvio Calise; Leo E Otterbein
Journal:  J Transplant       Date:  2011-12-14

8.  How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited.

Authors:  Mark A Atkinson; Jeffrey A Bluestone; George S Eisenbarth; Matthias Hebrok; Kevan C Herold; Domenico Accili; Massimo Pietropaolo; Peter R Arvan; Matthias Von Herrath; Dorene S Markel; Christopher J Rhodes
Journal:  Diabetes       Date:  2011-05       Impact factor: 9.461

9.  Autologous umbilical cord blood transfusion in very young children with type 1 diabetes.

Authors:  Michael J Haller; Clive H Wasserfall; Kieran M McGrail; Miriam Cintron; Todd M Brusko; John R Wingard; Susan S Kelly; Jonathan J Shuster; Mark A Atkinson; Desmond A Schatz
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 17.152

10.  Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.

Authors:  Matthew J Parker; Song Xue; John J Alexander; Clive H Wasserfall; Martha L Campbell-Thompson; Manuela Battaglia; Silvia Gregori; Clayton E Mathews; Sihong Song; Misty Troutt; Scott Eisenbeis; John Williams; Desmond A Schatz; Michael J Haller; Mark A Atkinson
Journal:  Diabetes       Date:  2009-07-23       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.